Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aptose Biosciences, Inc. - Common Shares
(NQ:
APTO
)
1.710
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptose Biosciences, Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
Next >
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024
↗
August 09, 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Aptose Reports Results for the Second Quarter 2024
August 08, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Announces Receipt of Deficiency Notice from Nasdaq
July 19, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Announces Results from Annual and Special Meeting of Shareholders
June 18, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Recap: Aptose Biosciences Q4 Earnings
↗
March 26, 2024
Via
Benzinga
Aptose Biosciences's Earnings: A Preview
↗
March 25, 2024
Via
Benzinga
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
June 14, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 03, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 31, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Biosciences: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024
↗
May 14, 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Aptose Reports Results for the First Quarter 2024
May 14, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
May 06, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023
↗
March 26, 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Aptose Reports Results for the Fourth Quarter and Full Year 2023
March 26, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
March 18, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
January 31, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 26, 2024
↗
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
Levi Strauss Layoffs 2024: What to Know About the Latest LEVI Job Cuts
↗
January 26, 2024
Levi Strauss layoffs are coming for as much as 15% of its corporate workforce as it prepares for a rough economy in 2024!
Via
InvestorPlace
Topics
Economy
Workforce
Why Is SU Group (SUGP) Stock Moving Today?
↗
January 26, 2024
SU Group stock volatile on Friday following the company's IPO earlier this week with shares currently trading below its debut price.
Via
InvestorPlace
Topics
Initial Public Offering
Why Is Aptose Biosciences (APTO) Stock Down Today?
↗
January 26, 2024
Aptose Biosciences stock is sliding lower on Friday as investors react to a public offering and private placement for APTO shares.
Via
InvestorPlace
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
January 26, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
↗
January 26, 2024
Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale. Tellurian shares jumped 16.3% to...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
January 26, 2024
Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!
Via
InvestorPlace
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
December 09, 2023
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
November 30, 2023
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Reports Results for the Third Quarter 2023
November 09, 2023
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
November 02, 2023
Data from the Ongoing APTIVATE International Phase 1/2 Study in Relapsed/Refractory AML Patients
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
October 30, 2023
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
October 30, 2023
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
